Company Filing History:
Years Active: 2001-2007
Title: Innovations of Shawn Barney in Viral Fusion Inhibitors
Introduction
Shawn Barney is an accomplished inventor based in Apex, NC (US), known for his significant contributions to the field of pharmacology. He holds a total of six patents, focusing primarily on enhancing the pharmacokinetic properties of therapeutic peptides. His work has the potential to impact treatments for various viral infections, including AIDS.
Latest Patents
One of Shawn Barney's latest patents is titled "DNA encoding T-1249 and other viral fusion inhibitor peptides useful for treating AIDS." This invention relates to enhancer peptide sequences derived from retroviral envelope (gp41) protein sequences. These sequences enhance the pharmacokinetic properties of core polypeptides to which they are linked. The discovery indicates that hybrid polypeptides comprising these enhancer sequences linked to a core polypeptide exhibit enhanced pharmacokinetic properties, such as increased half-life. The invention also outlines methods for improving the pharmacokinetic properties of any core polypeptide through the linkage of enhancer peptide sequences.
Career Highlights
Throughout his career, Shawn Barney has worked with notable companies, including Trimeris, Inc. and Cogent Neuroscience, Inc. His experience in these organizations has contributed to his expertise in developing innovative solutions in the field of viral treatments.
Collaborations
Shawn has collaborated with several professionals in his field, including Kelly I Guthrie and Gene Merutka. These collaborations have likely enriched his research and development efforts, leading to advancements in his patented technologies.
Conclusion
Shawn Barney's innovative work in the development of viral fusion inhibitors showcases his dedication to improving therapeutic options for patients. His patents reflect a commitment to enhancing the efficacy of treatments for serious viral infections.